Onyx Healthcare (ROCO:6569) PB Ratio: 2.65 (As of Jul. 12, 2026) — 26% Below Median


ROCO:6569 Onyx Healthcare Inc ROCO:6569
75 GF Score
Price NT$106.50
GF Value NT$121.39
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Onyx Healthcare PB Ratio?

Onyx Healthcare ROCO:6569 75 PB Ratio is 2.65 as of Jul. 12, 2026, which is 26% below its 10-year median of 3.56. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Onyx Healthcare ranks worse than 62.11% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), Onyx Healthcare's share price is NT$106.50. Onyx Healthcare's Book Value per Share for the quarter that ended in Dec. 2025 was NT$40.19. Hence, Onyx Healthcare's PB Ratio of today is 2.65.

The historical rank and industry rank for Onyx Healthcare's PB Ratio or its related term are showing as below:

ROCO:6569' s PB Ratio Range Over the Past 10 Years
Min: 2.26   Med: 3.56   Max: 13.82
Current: 2.65

During the past 13 years, Onyx Healthcare's highest PB Ratio was 13.82. The lowest was 2.26. And the median was 3.56.

ROCO:6569's PB Ratio is ranked worse than
62.11% of 607 companies
in the Healthcare Providers & Services industry
Industry Median: 2.01 vs ROCO:6569: 2.65

During the past 12 months, Onyx Healthcare's average Book Value Per Share Growth Rate was 0.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 3.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 7.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Onyx Healthcare was 64.70% per year. The lowest was 3.40% per year. And the median was 9.15% per year.

Back to Basics: PB Ratio


Onyx Healthcare  (ROCO:6569) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Onyx Healthcare PB Ratio Related Terms


Onyx Healthcare PB Ratio Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare PB Ratio Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.08 2.34 3.81 3.79 2.72

Onyx Healthcare Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.79 3.37 3.12 3.21 2.72

ROCO:6569 vs VEEV, BTSG, TEM: PB Ratio Comparison

For the Health Information Services subindustry, Onyx Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onyx Healthcare PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's PB Ratio distribution charts can be found below:

* The bar in red indicates where Onyx Healthcare's PB Ratio falls into.


ROCO:6569
75GF Score
Onyx Healthcare Inc ROCO:6569
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Healthcare PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Onyx Healthcare's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=106.50/40.187
=2.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 2.65 mean?
Onyx Healthcare (ROCO:6569) has a PB Ratio of 2.65 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Onyx Healthcare and its competitors. This is 26% below median its historical median of 3.56. Over the past decade, Onyx Healthcare's PB Ratio has ranged from 2.26 to 13.82. According to the industry distribution chart, Onyx Healthcare ranks #377 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 62.1%.
Is Onyx Healthcare's PB Ratio too high?
Onyx Healthcare's current PB Ratio of 2.65 is 26% below median its 10-year median of 3.56. Over the past 10 years, this metric has ranged from a low of 2.26 to a high of 13.82. The Healthcare Providers & Services industry median PB Ratio is 2.01. Onyx Healthcare's value of 2.65 is 31.8% above this industry median. Based on the distribution chart, Onyx Healthcare ranks #377 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #377 out of 607 companies for PB Ratio. This places Onyx Healthcare in the lower half of its industry. The industry median PB Ratio is 2.01. Onyx Healthcare's value of 2.65 is 31.8% above this benchmark. Historically, Onyx Healthcare's own PB Ratio has ranged from 2.26 to 13.82 over the past decade. While the company's 10-year median is 3.56 vs. the industry median of 2.01, Onyx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.01, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current PB Ratio of 2.65 is 31.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current PB Ratio is 2.65, which is 26% below median its own 10-year median of 3.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current PB Ratio is 2.65, which is 26% below median its 10-year median of 3.56 and 31.8% above the Healthcare Providers & Services industry median of 2.01. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current PB Ratio is 2.65 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • PB Ratio: 2.65 (26% below median its 10-year median of 3.56)
  • GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
  • GF Score™: 75/100 with 7 warning signs
  • Industry Position: 31.8% above the Healthcare Providers & Services median (#377 of 607)

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score

Get the complete analysis for ROCO:6569

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$106.50
Price
NT$121.39
GF Value